Get More Information on Injection Pen Market - Request Sample Report
The Injection Pen Market was valued at USD 40.6 billion in 2023 and is projected to reach USD 73.8 billion by 2032, with a growing CAGR of 6.8% over the forecast period 2024-2032.
The growing number of chronic diseases including osteoporosis, diabetes, cardiovascular conditions, and multiple sclerosis fueling some of the most significant demand drivers in the global injection pens market. Injection pens, especially for chronic therapies which typically require daily dosing, are an absolute necessity, for they make therapy easier to take and more convenient. The demand for new reusable and automated injection pens increases market growth. Healthcare workers have preferred automated pens more and more for enhanced safety, convenience, and accuracy in drug delivery.
Diabetes care has gained more attention throughout the world. With its subsequent rise in demand for insulin injections, it has become a major driving factor for the market. According to the Institute for Health Metrics and Evaluation, more than 500 million people worldwide suffer from diabetes; in three decades, this number will be over 1.3 billion. Diabetes is poised to rank as one of the world's top 10 causes of death and disability. Injection pens, particularly for insulin, registered higher sales than vials because the patient prefers a pen due to their ease and simplicity in self-administration.
Other than this, injection pens will enable patients suffering from chronic diseases to regulate their dosing schedules independently. The dosing is not as frequent, therefore patients and hospitals also benefit economically through the transition to homecare. In addition, the general population is aging, which translates to a growing patient population, especially concerning diseases such as diabetes, obesity, and disorders resulting from hormone imbalances.
The market is also based upon the introduction of advanced products along with an increasing trend towards smart medical devices and favorable government policies towards cost-effective healthcare solutions. Supportive reimbursement policies, as well as improved access to injection pens, especially in the home-care setting, will drive market growth in the coming years. Given that this synergy is striking, the global injection pens market is well-positioned to support long-term growth.
Drivers
Growing Demand for Injection Pens Driven by Diabetes Prevalence and Self-Administration Trends
High prevalence cases of diabetes mainly drive the need for injection pens. Half of all diabetic patients using injection pens for insulin treatment prefer them because they are easier and more comfortable than the traditional methods. A 2019 report by the OECD shows that around one-third of all adults in Britain have a high rate of obesity, the highest in Europe, making the use of injection pens a growing demand. Different formulations of insulin have also been invented to ensure safety in injections and minimize the chances of dosing errors. There is an increased release of new drugs for obesity and diabetes, which has increased demand in the market. Eli Lilly's Mounjaro drug, for instance, was launched in the UK in January 2024 and can be pre-filled in injection pens once approved.
Another vital driver is the growing patient demand for self-administration. Injection pens are made to make self-injection easier and more painless, while with high precision and accuracy, physicians can efficiently fine-tune dosages. Durable and pre-filled pens utilizing interchangeable cartridges of insulin support growth in the market. High technologies that deliver painless injections are in big demand for diabetes treatment and are likely to continue over the forecast period.
In addition, such a high demand for disposable injection pens is driving the market forward. Among them, disposable injection pens available in the market since 2022 account for a larger share and can be easily used without any risk of infection along with the exact dose. Competition among rivals will always be key to the safety use for patients.
Restraints
Challenges and Safety Concerns Hindering Injection Pen Market Growth
by Product
Reusable products dominated the 56.3% share in injection pens during 2023, with an estimated exponential growth rate during the forecast period as a result of growing emphasis on environmental sustainability in the healthcare sector. Disposable injection pens contribute to major plastic waste and cause a great deal of environmental issues; hence, patients and healthcare professionals are increasingly opting for reusable injection pens, which are sustainable.
In addition to these benefits, more economical methods of treatment are now also available for patients who require injections frequently through reusable pens. Also, switching to reusable pens can help reduce the overall cost for healthcare facilities. Further improvement in user-friendly designs through new technologies ensures proper delivery of the drug and the right dosage. Innovations that address concerns relating to convenience, as well as safety concerns, have also simplified cartridge replacement and sterilization better than before, hence making patient comfort and product dependability even better.
by Application
In 2023, diabetes was considered the largest market 35.6% driver for injection pens because of the numerous benefits that such pens have over the standard approach to insulin injections, mainly syringes and vials. Injection pens benefit users with better accuracy in dosing, ease of use, discretion, and improved mobility by those with diabetes who must deal with it every day. Poverty in eating habits that trigger abundant sugar levels in the blood is also another major factor in the development of type 1 diabetes, hence creating a large demand for the devices.
Anaphylaxis is likely to experience the highest compound annual growth rate during the forecast period. The major drivers behind this high growth rate are an increasing incidence of anaphylaxis among children all around the world and an increased demand for epinephrine auto-injectors, which are crucial to treat severe allergic reactions. Additionally, raised awareness of the life-threatening consequences of anaphylaxis has spurred physicians to prescribe auto-injectors more often.
by End-Use
In 2023, hospitals held the largest share 56.3% in the injection pens market. The growth in this market has been propelled by fast-paced adoption and government projects initiated for the betterment of health infrastructure. The market also experienced support from the growing population suffering from diabetes at this time. Other factors contributing to the growth are enhanced spending on health care by consumers, higher disposable incomes, and improved awareness of the use of injection pens. Factors adding to this need are the elderly population and the increasing incidence of diseases like diabetes. Most of their chronic illness injectable pen patients are treated in hospitals as this accommodates specialized infrastructure and high-end medical equipment, thereby treating a significant number of patients in such setups.
Clinics, however, are likely to be the segment with the highest CAGR over the review period. This can be attributed to the increasing prevalence of chronic disorders, which requires constant patient monitoring and management. Additionally, government programs that encourage patients to maintain the prescribed treatments and ensure better injection practices may enhance the use of injection pens among clinics, thereby contributing to the growth of this segment.
North America's injection pen market was the major contributor of 45.3% to the global market in 2023. by revenue share, the North American market is the largest contributor in the global market, and it accounts for almost 43.4%. This can mainly be attributed to the ever-increasing incidence of non-communicable diseases such as diabetes, cancer, cardiovascular diseases, and multiple sclerosis, primarily across the U.S. and Canada. With higher healthcare spending, increased awareness of advanced drug delivery systems, and easy availability of injection pens and cartridges, growth in this region is supported.
The market in Europe injection pens also looks promising enough for 2023, mainly because of the aging population in this continent. Europe is a global leader in the conductance of clinical trials: it features among the five largest clinical trial conductors in the world. The present EU Clinical Trials Register lists more than 43,000 clinical trials with an EudraCT protocol, which speaks well of its commitment to advancing medical research and supporting the injection pen market.
The most promising is the Asia Pacific injection pen market with potentially strong growth for the future. This growth will be fueled by increasingly rapid incidences of chronic diseases like diabetes, largely supported by rapid urbanization, changing lifestyles, and an aging population that is increasing demand for injection pens for self-administration of insulin and other drugs. It commands a large market share in China. Currently, in 2023, changes in demographics and lifestyle continue to fuel demand. However, the main driver remains the elderly population as this increases the prevalence of diseases such as diabetes, which has fueled the growth of the market.
Need any customization research on Injection Pen Market - Enquiry Now
Key Players
BD (BD Ultra-Fine Insulin Pen Needles, BD Insulin Pen)
Lilly (Mounjaro (Tirzepatide), Humalog KwikPen, Basaglar KwikPen, Trulicity (auto-injector))
Ypsomed AG (MyLife YpsoPen, MyLife Clickfine Pen Needles)
Biocon (Basalog, Insulin Aspart Pen)
AstraZeneca (Fasenra (auto-injector), bydureon Pen)
Pfizer Inc. (Enbrel SureClick)
Novartis AG (Aimovig, Zolgensma)
Novo Nordisk A/S (Ozempic)
Sanofi (Admelog SoloSTAR)
Owen Mumford Ltd. (AutoJet)
Merck KGaA (Bavencio)
Hoffman-La Roche (Rituxan Hycela)
Medtronic (MiniMed Insulin Pen)
Wockhardt Ltd. (Wockhardt Insulin Lispro Injection)
Sun Pharmaceutical Industries Ltd. (Sun Insulin Aspart Injection) and others.
Recent Developments
In February 2024, Eli Lilly launched the Mounjaro drug in the UK, marking the fourth European country to introduce this much-anticipated obesity medication. The MHRA approved a four-dose version of Mounjaro (tirzepatide), known as the Mounjaro KwikPen, for managing both diabetes and weight control.
In February 2023, Sanofi partnered with Glooko Inc. to strengthen diabetes care for both individuals and healthcare providers by integrating SoloSmart with the Glooko platform. This collaboration aims to expand access to digital tools for diabetes management in all the markets where SoloSmart will be available.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 40.6 Billion |
| Market Size by 2032 | USD 73.8 Billion |
| CAGR | CAGR of 6.8% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Disposable, Reusable) • By Application (Diabetes, Anaphylaxis, Osteoporosis, Growth Hormone Deficiency, Arthritis, Others) • By End-Use (Hospital, Clinics, Home Care Settings) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia-Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia-Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | BD, Lilly, Ypsomed AG, Biocon, AstraZeneca, Pfizer Inc., Novartis AG, Novo Nordisk A/S, Sanofi, Owen Mumford Ltd., Merck KGaA, Hoffman-La Roche, Medtronic, Wockhardt Ltd., Sun Pharmaceutical Industries Ltd. and Others |
| Key Drivers | • Growing Demand for Injection Pens Driven by Diabetes Prevalence and Self-Administration Trends |
| Restraints | • Challenges and Safety Concerns Hindering Injection Pen Market Growth |
The estimated compound annual growth rate is 6.8% during the forecast period for the Injection Pen market.
The projected market value of the Injection Pen market is estimated at USD 40.6 billion in 2023 and is expected to reach USD 73.8 billion by 2032.
The growing demand for injection pens is driven by diabetes prevalence and self-administration trends.
Challenges and safety concerns hindering injection pen market growth.
North America is the dominant region with a 45.3% share in the Injection Pen market.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, by Region
6.2 Market Share Analysis, by Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Injection Pen Market Segmentation, by Product
7.1 Chapter Overview
7.2 Disposable
7.2.1 Disposable Market Trends Analysis (2020-2032)
7.2.2 Disposable Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Reusable
7.3.1 Reusable Market Trends Analysis (2020-2032)
7.3.2 Reusable Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Injection Pen Market Segmentation, by Application
8.1 Chapter Overview
8.2 Diabetes
8.2.1 Diabetes Market Trends Analysis (2020-2032)
8.2.2 Diabetes Market Size Estimates and Forecasts to 2032 (USD Million)
8.3 Anaphylaxis
8.3.1 Anaphylaxis Market Trends Analysis (2020-2032)
8.3.2 Anaphylaxis Market Size Estimates and Forecasts to 2032 (USD Million)
8.4 Osteoporosis
8.4.1 Osteoporosis Market Trends Analysis (2020-2032)
8.4.2 Osteoporosis Market Size Estimates and Forecasts to 2032 (USD Million)
8.5 Growth Hormone Deficiency
8.5.1 Growth Hormone Deficiency Market Trends Analysis (2020-2032)
8.5.2 Growth Hormone Deficiency Market Size Estimates and Forecasts to 2032 (USD Million)
8.6 Arthritis
8.6.1 Arthritis Market Trends Analysis (2020-2032)
8.6.2 Arthritis Market Size Estimates and Forecasts to 2032 (USD Million)
8.7 Others
8.7.1 Others Market Trends Analysis (2020-2032)
8.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Million)
9. Injection Pen Market Segmentation, by End-Use
9.1 Chapter Overview
9.2 Hospital
9.2.1 Hospital Market Trends Analysis (2020-2032)
9.2.2 Hospital Market Size Estimates and Forecasts to 2032 (USD Million)
9.3 Clinics
9.3.1 Clinics Market Trends Analysis (2020-2032)
9.3.2 Clinics Market Size Estimates and Forecasts to 2032 (USD Million)
9.4 Home Care Settings
9.4.1 Home Care Settings Market Trends Analysis (2020-2032)
9.4.2 Home Care Settings Market Size Estimates and Forecasts to 2032 (USD Million)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Injection Pen Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.2.3 North America Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.2.4 North America Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.2.5 North America Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.2.6 USA
10.2.6.1 USA Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.2.6.2 USA Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.2.6.3 USA Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.2.7 Canada
10.2.7.1 Canada Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.2.7.2 Canada Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.2.7.3 Canada Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.2.8 Mexico
10.2.8.1 Mexico Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.2.8.2 Mexico Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.2.8.3 Mexico Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Injection Pen Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.3.1.3 Eastern Europe Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.3.1.4 Eastern Europe Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.5 Eastern Europe Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.3.1.6 Poland
10.3.1.6.1 Poland Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.3.1.6.2 Poland Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.6.3 Poland Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.3.1.7 Romania
10.3.1.7.1 Romania Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.3.1.7.2 Romania Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.7.3 Romania Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.3.1.8.2 Hungary Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.8.3 Hungary Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.3.1.9 turkey
10.3.1.9.1 Turkey Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.3.1.9.2 Turkey Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.9.3 Turkey Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.3.1.10.2 Rest of Eastern Europe Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.10.3 Rest of Eastern Europe Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Injection Pen Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.3.2.3 Western Europe Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.3.2.4 Western Europe Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.5 Western Europe Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.3.2.6 Germany
10.3.2.6.1 Germany Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.3.2.6.2 Germany Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.6.3 Germany Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.3.2.7 France
10.3.2.7.1 France Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.3.2.7.2 France Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.7.3 France Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.3.2.8 UK
10.3.2.8.1 UK Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.3.2.8.2 UK Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.8.3 UK Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.3.2.9 Italy
10.3.2.9.1 Italy Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.3.2.9.2 Italy Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.9.3 Italy Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.3.2.10 Spain
10.3.2.10.1 Spain Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.3.2.10.2 Spain Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.10.3 Spain Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.3.2.11.2 Netherlands Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.11.3 Netherlands Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.3.2.12.2 Switzerland Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.12.3 Switzerland Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.3.2.13 Austria
10.3.2.13.1 Austria Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.3.2.13.2 Austria Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.13.3 Austria Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.3.2.14.2 Rest of Western Europe Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.14.3 Rest of Western Europe Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Injection Pen Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.4.3 Asia Pacific Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.4.4 Asia Pacific Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.5 Asia Pacific Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.4.6 China
10.4.6.1 China Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.4.6.2 China Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.6.3 China Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.4.7 India
10.4.7.1 India Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.4.7.2 India Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.7.3 India Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.4.8 Japan
10.4.8.1 Japan Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.4.8.2 Japan Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.8.3 Japan Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.4.9 South Korea
10.4.9.1 South Korea Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.4.9.2 South Korea Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.9.3 South Korea Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.4.10 Vietnam
10.4.10.1 Vietnam Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.4.10.2 Vietnam Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.10.3 Vietnam Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.4.11 Singapore
10.4.11.1 Singapore Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.4.11.2 Singapore Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.11.3 Singapore Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.4.12 Australia
10.4.12.1 Australia Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.4.12.2 Australia Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.12.3 Australia Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.4.13.2 Rest of Asia Pacific Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.13.3 Rest of Asia Pacific Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Injection Pen Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.1.3 Middle East Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.5.1.4 Middle East Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.5 Middle East Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.5.1.6 UAE
10.5.1.6.1 UAE Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.5.1.6.2 UAE Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.6.3 UAE Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.5.1.7.2 Egypt Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.7.3 Egypt Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.5.1.8.2 Saudi Arabia Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.8.3 Saudi Arabia Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.5.1.9.2 Qatar Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.9.3 Qatar Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.5.1.10.2 Rest of Middle East Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.10.3 Rest of Middle East Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Injection Pen Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.2.3 Africa Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.5.2.4 Africa Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.2.5 Africa Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.5.2.6.2 South Africa Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.2.6.3 South Africa Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.5.2.7.2 Nigeria Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.2.7.3 Nigeria Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.5.2.8.2 Rest of Africa Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.2.8.3 Rest of Africa Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Injection Pen Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.6.3 Latin America Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.6.4 Latin America Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.5 Latin America Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.6.6 Brazil
10.6.6.1 Brazil Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.6.6.2 Brazil Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.6.3 Brazil Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.6.7 Argentina
10.6.7.1 Argentina Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.6.7.2 Argentina Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.7.3 Argentina Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.6.8 Colombia
10.6.8.1 Colombia Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.6.8.2 Colombia Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.8.3 Colombia Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Injection Pen Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
10.6.9.2 Rest of Latin America Injection Pen Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.9.3 Rest of Latin America Injection Pen Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
11. Company Profiles
11.1 BD
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Lilly
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Ypsomed AG
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Biocon
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 AstraZeneca
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Pfizer Inc.
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Novartis AG
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Novo Nordisk A/S
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 Medtronic
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Merck KGaA
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segmentation
By Product
Disposable
Reusable
By Application
Diabetes
Anaphylaxis
Osteoporosis
Growth Hormone Deficiency
Arthritis
Others
By End-Use
Hospital
Clinics
Home Care Settings
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Drug Delivery Systems Market was valued at USD 42.80 Billion in 2023 and is expected to reach USD 87.82 Billion By 2031 and grow at a CAGR of 9.4% over the forecast period of 2024-2031.
The Precision Diagnostics Market Size was valued at USD 75.87 Billion in 2023 and is expected to reach USD 224.53 Billion by 2032 and grow at a CAGR of 13.50% over the forecast period 2024-2032.
The Medical Swabs Market was valued at USD 3.15 billion in 2023 and is expected to reach USD 5.69 billion by 2032, growing at a CAGR of 6.8% by 2024-2032.
The Genotyping Market Size was valued at USD 17.24 billion in 2023, and is expected to reach USD 58.80 billion by 2032, and grow at a CAGR of 14.6% over the forecast period 2024-2032.
The Laboratory Informatics Market Size was esteemed at USD 3.45 billion 2023, and expected to arrive at USD 5.09 billion by 2031, and develop at a CAGR of 5% over the conjecture period 2024-2031.
The Global Biosimilars Market Size was USD 29.51 Billion in 2023 and expected to reach USD 127.92 Billion By 2032 and grow at a CAGR of 17.7% by 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
